Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colo...
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
About this item
Full title
Author / Creator
Publisher
England: BMJ Publishing Group LTD
Journal title
Language
English
Formats
Publication information
Publisher
England: BMJ Publishing Group LTD
Subjects
More information
Scope and Contents
Contents
Aims To determine whether expression of Smad4, a tumour suppressor found to be absent in 10% of colorectal cancer (CRC), is associated with outcomes in patients with CRC. Methods Tumour samples from 241 consecutive patients with CRC who underwent upfront colon resection between 2005 and 2009 were obtained. Triplicate tissue cores from resected prim...
Alternative Titles
Full title
Smad4 inactivation predicts for worse prognosis and response to fluorouracil-based treatment in colorectal cancer
Authors, Artists and Contributors
Identifiers
Primary Identifiers
Record Identifier
TN_cdi_proquest_miscellaneous_1808684998
Permalink
https://devfeature-collection.sl.nsw.gov.au/record/TN_cdi_proquest_miscellaneous_1808684998
Other Identifiers
ISSN
0021-9746
E-ISSN
1472-4146
DOI
10.1136/jclinpath-2014-202660
